{"hands_on_practices": [{"introduction": "Moving from theory to application requires the ability to navigate a complex decision landscape. This practice [@problem_id:2713059] serves as a realistic case study, challenging you to select the optimal genome editing strategy for a therapeutic application in neuroscience. By weighing critical factors such as delivery constraints, cell-type-specific DNA repair, and the chemical nature of the desired edit, you will learn to construct a decision framework that mirrors the strategic thinking required for successful *in vivo* gene editing.", "problem": "A laboratory plans to correct a pathogenic single-nucleotide variant in excitatory cortical neurons of adult mice in vivo. The mutant allele is a guanine-to-adenine transition in the coding sequence of a synaptic protein gene on the sense strand. The editing must be delivered by Adeno-Associated Virus (AAV) vectors systemically with central nervous system tropism and neuron-restricted promoters, and the investigators can only use AAV serotype 9-like vectors with a per-vector packaging capacity of approximately $4.7$ kilobases. The laboratory can consider Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas systems delivered by single or dual AAV vectors with split-inteins, accepting the co-transduction penalty of dual delivery. The goal is to achieve at least $20\\%$ correction in transduced neurons without introducing double-strand break-associated neurotoxicity or clinically significant off-target edits.\n\nFundamental constraints and definitions to ground the decision are as follows:\n\n- Central dogma and gene function: A pathogenic coding variant that changes an amino acid can be corrected by restoring the original codon. If the edit restores the coding sequence, normal messenger ribonucleic acid (mRNA) and protein are expressed.\n- Double-strand break (DSB) repair in neurons: Adult neurons are postmitotic in $\\mathrm{G}0$ and predominantly use Non-Homologous End Joining (NHEJ) and microhomology-mediated end joining, whereas Homology-Directed Repair (HDR) is inefficient outside $\\mathrm{S}/\\mathrm{G}2$. DSBs can activate p53 signaling and are neurotoxic.\n- Editing modalities: Cas9 nuclease generates DSBs requiring repair (NHEJ or HDR). Base editors fuse a catalytically impaired Cas9 to a deaminase to install transition edits without DSBs (cytosine base editors perform $\\mathrm{C}\\rightarrow \\mathrm{T}$ or $\\mathrm{G}\\rightarrow \\mathrm{A}$; adenine base editors perform $\\mathrm{A}\\rightarrow \\mathrm{G}$ or $\\mathrm{T}\\rightarrow \\mathrm{C}$) within a defined editing window relative to the protospacer. Prime editors fuse a Cas9 nickase to a reverse transcriptase and use a prime editing guide RNA to write small substitutions, insertions, or deletions without DSBs.\n- Delivery and size: Streptococcus pyogenes Cas9 (SpCas9) coding sequence is approximately $4.1$ kilobases, Staphylococcus aureus Cas9 (SaCas9) is approximately $3.2$ kilobases. Base editors and prime editors are larger (often greater than $5.0$ kilobases for base editors and approximately $6.3$ kilobases for prime editors), typically necessitating dual AAV delivery when using neuronally active promoters and regulatory elements. Dual AAV reduces the fraction of cells expressing a full editor due to the need for co-transduction.\n- Protospacer adjacent motif (PAM) and window: The only NGG PAM within $20$ nucleotides of the target places the mutant adenine on the sense strand at position $13$ relative to the protospacer, outside the canonical adenine base editor window (positions $4$–$8$ for many variants). However, an NNGRRT PAM available for SaCas9 positions the target adenine at position $6$ of the protospacer on the sense strand, with no additional adenines within positions $4$–$8$ of that protospacer.\n- Off-target considerations: DSB-based editing risks off-target cleavage; base editing risks bystander deamination within the editing window and potential guide-dependent off-target binding; prime editing has high sequence specificity but lower editing efficiency in adult neurons reported to date, especially with dual AAV delivery.\n\nConstruct a decision framework from these first principles that weighs: edit type feasibility (transition versus transversion or indel), avoidance of DSBs in postmitotic neurons, delivery feasibility under AAV size constraints, on-target efficiency needed (at least $20\\%$ in transduced cells), and specificity (avoidance of harmful bystanders), and then apply it to select the single best modality and implementation for this target under the stated constraints.\n\nWhich option below is the most appropriate choice according to such a framework?\n\nA. Use SpCas9 nuclease with a single-stranded oligodeoxynucleotide donor to install the desired base by Homology-Directed Repair, delivered by a single AAV9 vector with a ubiquitous promoter to maximize expression and efficiency.\n\nB. Use an adenine base editor built on SaCas9 recognizing the NNGRRT PAM that places the mutant adenine at position $6$ in the editing window, delivered via dual AAV9 vectors with split-inteins and a neuron-specific promoter; include a high-fidelity SaCas9 variant to reduce off-target binding.\n\nC. Use prime editing version $3$ (PE$3$) built on SpCas9 nickase and reverse transcriptase delivered via dual AAV9 vectors, with a pegRNA encoding the desired $\\mathrm{A}\\rightarrow \\mathrm{G}$ correction and a nicking single-guide RNA to boost efficiency, accepting lower per-cell expression.\n\nD. Use SpCas9 nuclease to induce a DSB adjacent to the mutation and rely on microhomology-mediated end joining to stochastically revert the allele, delivered as a ribonucleoprotein complex packaged into AAV9 to avoid persistent expression.\n\nE. Use a cytosine base editor targeting the antisense strand to convert the mutant base back to wild type because cytosine deamination can correct purine transitions on the opposite strand.", "solution": "The task is to determine the single best genome editing strategy to correct a specific pathogenic mutation in adult mouse neurons *in vivo*, based on a comprehensive set of constraints and definitions. I shall first validate the problem statement and then construct a decision framework to evaluate the given options.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n-   **Target:** Excitatory cortical neurons in adult mice, *in vivo*.\n-   **Mutation:** A pathogenic guanine-to-adenine ($\\mathrm{G} \\rightarrow \\mathrm{A}$) transition on the sense strand of a gene.\n-   **Required Correction:** An adenine-to-guanine ($\\mathrm{A} \\rightarrow \\mathrm{G}$) edit on the sense strand to restore the wild-type sequence.\n-   **Delivery Vector:** Adeno-Associated Virus (AAV), serotype 9-like, with neuron-restricted promoters.\n-   **Vector Constraint:** Packaging capacity of approximately $4.7$ kilobases (kb) per vector.\n-   **Delivery Strategy:** Single or dual AAV (with split-inteins) are permissible; co-transduction penalty for dual AAV is accepted.\n-   **Efficacy Requirement:** At least $20\\%$ correction in transduced neurons.\n-   **Safety Requirement:** Must avoid double-strand break (DSB)-associated neurotoxicity and significant off-target edits.\n-   **Cellular Physiology:** Adult neurons are postmitotic ($\\mathrm{G}0$), rendering Homology-Directed Repair (HDR) inefficient and making them sensitive to DSBs.\n-   **Editor Sizes:** SpCas9 $\\approx 4.1$ kb, SaCas9 $\\approx 3.2$ kb, Base Editors (BE)  $5.0$ kb, Prime Editors (PE) $\\approx 6.3$ kb.\n-   **PAM/Protospacer Context:**\n    -   An SpCas9 PAM (NGG) is available but places the target adenine (A) at position $13$ of the protospacer, which is outside the canonical adenine base editor (ABE) activity window (positions $4$–$8$).\n    -   An SaCas9 PAM (NNGRRT) is available and places the target A at position $6$ within the protospacer. No other adenines exist in the canonical window ($4$–$8$) of this protospacer, precluding bystander edits.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem statement is scientifically grounded, well-posed, and objective. It presents a realistic scenario in neuro-therapeutic gene editing, detailing a multi-factorial optimization problem. The provided biological principles (central dogma, neuronal DNA repair), technological specifications (editor types, sizes, PAMs), and constraints (AAV capacity, safety, efficiency) are factually accurate and consistent. The problem is not underspecified, contradictory, or trivial. It requires a rigorous application of first principles to arrive at a solution.\n\n**Step 3: Verdict and Action**\nThe problem is valid. I will proceed to derive the solution.\n\n### Derivation of the Optimal Strategy\n\nA decision framework must be constructed based on the primary constraints:\n1.  **Safety (Avoidance of DSBs):** The problem states that adult neurons are postmitotic and DSBs are neurotoxic. This is a critical, non-negotiable constraint. Therefore, any strategy deploying a catalytically active nuclease that generates DSBs (e.g., standard SpCas9 or SaCas9) is contraindicated. This immediately rules out HDR and NHEJ/MMEJ-based correction strategies as primary options due to unacceptable risk. We must prioritize DSB-free modalities like base editing or prime editing, which use Cas nickases (nCas9) or dead Cas9 (dCas9).\n\n2.  **Chemical Feasibility (Edit Type):** The goal is to correct an $A$ on the sense strand to a $G$. This is an $\\mathrm{A} \\rightarrow \\mathrm{G}$ transition.\n    -   **Adenine Base Editors (ABEs):** These are specifically designed to catalyze $\\mathrm{A} \\rightarrow \\mathrm{G}$ (and $\\mathrm{T} \\rightarrow \\mathrm{C}$) transitions. This is a perfect match.\n    -   **Cytosine Base Editors (CBEs):** These catalyze $\\mathrm{C} \\rightarrow \\mathrm{T}$ (and $\\mathrm{G} \\rightarrow \\mathrm{A}$) transitions. To achieve an $\\mathrm{A} \\rightarrow \\mathrm{G}$ edit, a CBE would have to target the antisense strand, which contains a thymine (T). A CBE cannot edit a T. Thus, a CBE is chemically unsuitable for this task.\n    -   **Prime Editors (PEs):** These can install any small edit, including an $\\mathrm{A} \\rightarrow \\mathrm{G}$ transition. This is chemically feasible.\n    -   **HDR:** This can install any edit if a template is provided, but it is mechanistically inefficient in neurons.\n\n3.  **Targetability and Specificity (PAM/Window):** The editor must be able to access the target base.\n    -   The problem states that for the available SpCas9 NGG PAM, the target A is at position $13$, outside the canonical ABE window. This makes an SpCas9-based ABE non-viable or highly inefficient for this specific target.\n    -   Crucially, an SaCas9 NNGRRT PAM is available that positions the target A at position $6$, which is ideal for an ABE. The problem also states there are no other adenines in the editing window, meaning the risk of \"bystander\" edits (unintended edits of nearby adenines) is zero for this specific guide RNA. This makes the SaCas9-based ABE strategy highly specific and well-suited for this target.\n\n4.  **Delivery Feasibility (AAV Packaging):** The AAV capacity is $\\sim 4.7$ kb.\n    -   A nuclease-only system (SpCas9 or SaCas9) can fit in a single AAV. However, this approach was ruled out on safety grounds.\n    -   Base editors ($5.0$ kb) and Prime editors ($\\approx$$6.3$ kb) are too large for a single AAV when co-expressed with a neuron-specific promoter and other regulatory elements. They require a dual AAV delivery system (e.g., split-intein), which the problem explicitly permits.\n\n5.  **Efficacy (Efficiency Target):** The chosen method must achieve at least $20\\%$ correction.\n    -   **HDR:** Efficiency is negligible in postmitotic neurons. It will not meet the target.\n    -   **Prime Editing:** The problem states PE has \"lower editing efficiency in adult neurons reported to date, especially with dual AAV delivery.\" This makes achieving the $20\\%$ threshold uncertain and presents a significant risk of failure.\n    -   **Base Editing:** ABEs are known for high efficiency *in vivo*. While dual AAV delivery reduces the total number of cells receiving the complete editor, the per-cell editing efficiency is high, making it the most probable strategy to meet or exceed the $20\\%$ target.\n\n**Conclusion of Framework:**\nThe optimal strategy must be DSB-free, chemically capable of an $\\mathrm{A} \\rightarrow \\mathrm{G}$ edit, possess a suitable PAM and editing window, be deliverable via AAV, and be efficient enough to meet the $20\\%$ goal. The SaCas9-based Adenine Base Editor is the only modality that satisfies all criteria simultaneously and optimally. It avoids DSBs, is chemically correct, has a perfectly positioned target site with no bystander risk, can be delivered via the permitted dual AAV strategy, and has the highest likelihood of achieving the required efficiency.\n\n### Evaluation of Options\n\n**A. Use SpCas9 nuclease with a single-stranded oligodeoxynucleotide donor to install the desired base by Homology-Directed Repair, delivered by a single AAV9 vector with a ubiquitous promoter to maximize expression and efficiency.**\nThis option proposes an HDR-based strategy. This is incorrect for two primary reasons. First, it requires a DSB from SpCas9 nuclease, violating the critical safety constraint to avoid neurotoxicity. Second, HDR is profoundly inefficient in postmitotic neurons and would fail to meet the $20\\%$ efficiency requirement. Additionally, a ubiquitous promoter is contrary to the specified need for a neuron-restricted promoter.\n**Verdict: Incorrect.**\n\n**B. Use an adenine base editor built on SaCas9 recognizing the NNGRRT PAM that places the mutant adenine at position 6 in the editing window, delivered via dual AAV9 vectors with split-inteins and a neuron-specific promoter; include a high-fidelity SaCas9 variant to reduce off-target binding.**\nThis option is perfectly aligned with the derived optimal strategy. It uses an ABE, which is the correct DSB-free tool for an $\\mathrm{A} \\rightarrow \\mathrm{G}$ edit. It correctly selects SaCas9 to match the available PAM and optimal editing window position. It notes the absence of bystander targets. It correctly identifies the necessity of a dual AAV delivery system, which is allowed. It specifies a neuron-specific promoter as required. Including a high-fidelity variant further strengthens the safety profile. This strategy has the highest probability of being both safe and effective.\n**Verdict: Correct.**\n\n**C. Use prime editing version 3 (PE3) built on SpCas9 nickase and reverse transcriptase delivered via dual AAV9 vectors, with a pegRNA encoding the desired A-G correction and a nicking single-guide RNA to boost efficiency, accepting lower per-cell expression.**\nThis option proposes a DSB-free method that is chemically capable of the edit and is deliverable via dual AAVs. However, the problem explicitly states that PE has \"lower editing efficiency in adult neurons reported to date\". Given the strict $\\geq 20\\%$ efficiency requirement, this represents a less reliable choice compared to the highly efficient ABE. While PE is a valid technology, it is not the *most appropriate choice* under the specified constraints, which favor the higher probability of success offered by the ABE.\n**Verdict: Incorrect.**\n\n**D. Use SpCas9 nuclease to induce a DSB adjacent to the mutation and rely on microhomology-mediated end joining to stochastically revert the allele, delivered as a ribonucleoprotein complex packaged into AAV9 to avoid persistent expression.**\nThis option is fundamentally flawed. It relies on a DSB, which is neurotoxic. MMEJ is an error-prone repair pathway that primarily causes deletions, not precise single-nucleotide corrections. Relying on it for a \"stochastic reversion\" is not a viable scientific strategy; the outcome would almost certainly be gene knockout, not correction. Finally, packaging large RNP complexes into AAVs is not the standard or efficient delivery modality described.\n**Verdict: Incorrect.**\n\n**E. Use a cytosine base editor targeting the antisense strand to convert the mutant base back to wild type because cytosine deamination can correct purine transitions on the opposite strand.**\nThis option demonstrates a misunderstanding of base editor chemistry. The goal is an $\\mathrm{A} \\rightarrow \\mathrm{G}$ edit on the sense strand, which means a $\\mathrm{T} \\rightarrow \\mathrm{C}$ edit is needed on the antisense strand. A cytosine base editor (CBE) edits C to T. It cannot edit a T. Therefore, a CBE is the wrong tool for the job.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{B}$$", "id": "2713059"}, {"introduction": "When using CRISPR-Cas9 nuclease to create a gene knockout, the goal is often to induce a frameshift mutation. This exercise [@problem_id:2713068] provides a quantitative framework for predicting the likelihood of this outcome based on empirical data from non-homologous end joining (NHEJ). By applying the law of total probability to known distributions of insertion and deletion events, you will calculate the expected probability of disrupting a gene's reading frame, a fundamental skill for designing effective knockout experiments.", "problem": "A CRISPR-associated protein 9 (Cas9) nuclease is used to introduce a double-strand break within a coding exon of a neuronally expressed gene. Repair by non-homologous end joining is modeled as producing a single insertion or deletion (indel) event at the cut site with an insertion versus deletion bias of $P(\\text{insertion})=\\frac{1}{3}$ and $P(\\text{deletion})=\\frac{2}{3}$. Conditional on an insertion occurring, the empirical insertion length distribution (in nucleotides) is:\n- $P(L=1 \\mid \\text{insertion})=0.90$,\n- $P(L=2 \\mid \\text{insertion})=0.08$,\n- $P(L=3 \\mid \\text{insertion})=0.02$.\n\nConditional on a deletion occurring, the empirical deletion length distribution (in nucleotides) is:\n- $P(L=1 \\mid \\text{deletion})=0.20$,\n- $P(L=2 \\mid \\text{deletion})=0.20$,\n- $P(L=3 \\mid \\text{deletion})=0.15$,\n- $P(L=4 \\mid \\text{deletion})=0.10$,\n- $P(L=5 \\mid \\text{deletion})=0.10$,\n- $P(L=6 \\mid \\text{deletion})=0.08$,\n- $P(L=7 \\mid \\text{deletion})=0.06$,\n- $P(L=8 \\mid \\text{deletion})=0.04$,\n- $P(L=9 \\mid \\text{deletion})=0.03$,\n- $P(L=10 \\mid \\text{deletion})=0.02$,\n- $P(L=11 \\mid \\text{deletion})=0.01$,\n- $P(L=12 \\mid \\text{deletion})=0.01$.\n\nAssume the cut lies within the coding sequence and that the pre-edit messenger ribonucleic acid (mRNA) reading frame is correct. Using only the foundational fact from the Central Dogma that protein-coding sequences are read in codons of length $3$ nucleotides, compute the expected probability that a single indel generated by Cas9 at this site disrupts the reading frame (i.e., yields a frameshift), conditional on an indel occurring and drawn from the distributions above.\n\nState any additional simplifying assumptions you invoke. Express your final answer as a decimal (not a percentage), rounded to four significant figures.", "solution": "The problem requires the computation of a probability and must first be validated for scientific and logical integrity.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe givens are as follows:\n- A double-strand break is introduced in a coding exon.\n- Repair by non-homologous end joining (NHEJ) produces a single insertion or deletion (indel).\n- Probability of insertion: $P(\\text{insertion}) = \\frac{1}{3}$.\n- Probability of deletion: $P(\\text{deletion}) = \\frac{2}{3}$.\n- Conditional probability distribution for insertion length $L$ (in nucleotides):\n    - $P(L=1 \\mid \\text{insertion}) = 0.90$\n    - $P(L=2 \\mid \\text{insertion}) = 0.08$\n    - $P(L=3 \\mid \\text{insertion}) = 0.02$\n- Conditional probability distribution for deletion length $L$ (in nucleotides):\n    - $P(L=1 \\mid \\text{deletion}) = 0.20$\n    - $P(L=2 \\mid \\text{deletion}) = 0.20$\n    - $P(L=3 \\mid \\text{deletion}) = 0.15$\n    - $P(L=4 \\mid \\text{deletion}) = 0.10$\n    - $P(L=5 \\mid \\text{deletion}) = 0.10$\n    - $P(L=6 \\mid \\text{deletion}) = 0.08$\n    - $P(L=7 \\mid \\text{deletion}) = 0.06$\n    - $P(L=8 \\mid \\text{deletion}) = 0.04$\n    - $P(L=9 \\mid \\text{deletion}) = 0.03$\n    - $P(L=10 \\mid \\text{deletion}) = 0.02$\n    - $P(L=11 \\mid \\text{deletion}) = 0.01$\n    - $P(L=12 \\mid \\text{deletion}) = 0.01$\n- Fundamental Principle: Protein-coding sequences are read in codons of length $3$ nucleotides.\n- Objective: Compute the probability of a frameshift mutation.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem is scientifically grounded, as it describes a simplified but correct model of indel formation via NHEJ following a CRISPR-Cas9 induced double-strand break. The central concept that an indel whose length is not a multiple of $3$ causes a frameshift is a cornerstone of molecular genetics. The problem is well-posed, providing all necessary probability distributions to calculate the required value. The provided probabilities are internally consistent:\n- For insertions: $0.90 + 0.08 + 0.02 = 1.00$.\n- For deletions: $0.20 + 0.20 + 0.15 + 0.10 + 0.10 + 0.08 + 0.06 + 0.04 + 0.03 + 0.02 + 0.01 + 0.01 = 1.00$.\n- The two event types, insertion and deletion, are mutually exclusive and exhaustive within the model: $P(\\text{insertion}) + P(\\text{deletion}) = \\frac{1}{3} + \\frac{2}{3} = 1$.\nThe problem is objective and free of ambiguity. It requires a direct application of probability theory to a biological scenario. No flaws are identified.\n\n**Step 3: Verdict and Action**\n\nThe problem is valid. A solution will be provided.\n\n### Solution\n\nThe objective is to calculate the total probability of a frameshift mutation, which we denote as $P(F)$. A frameshift mutation occurs if and only if the length of the indel, $L$, is not a multiple of $3$. Mathematically, this condition is $L \\pmod 3 \\neq 0$.\n\nThe problem states that any indel is either an insertion (event $I$) or a deletion (event $D$). These are mutually exclusive events. Therefore, we can use the law of total probability to find the overall probability of a frameshift:\n$$P(F) = P(F \\mid I)P(I) + P(F \\mid D)P(D)$$\nwhere $P(F \\mid I)$ is the probability of a frameshift given an insertion occurred, and $P(F \\mid D)$ is the probability of a frameshift given a deletion occurred. The problem provides the prior probabilities $P(I) = \\frac{1}{3}$ and $P(D) = \\frac{2}{3}$.\n\nFirst, we compute the conditional probability of a frameshift given an insertion, $P(F \\mid I)$. This is the probability that the insertion length $L$ is not a multiple of $3$. From the given distribution, insertions can have lengths $L=1, L=2,$ or $L=3$. The only length that is a multiple of $3$ is $L=3$. Therefore, a frameshift occurs if $L=1$ or $L=2$.\n$$P(F \\mid I) = P(L=1 \\mid I) + P(L=2 \\mid I)$$\n$$P(F \\mid I) = 0.90 + 0.08 = 0.98$$\nAlternatively, we can calculate this as $1$ minus the probability of an in-frame mutation:\n$$P(F \\mid I) = 1 - P(L=3 \\mid I) = 1 - 0.02 = 0.98$$\nThe results are consistent.\n\nNext, we compute the conditional probability of a frameshift given a deletion, $P(F \\mid D)$. This is the probability that the deletion length $L$ is not a multiple of $3$. From the given distribution for deletions, the possible lengths are $L \\in \\{1, 2, ..., 12\\}$. The lengths that are multiples of $3$ (and thus cause in-frame mutations) are $L \\in \\{3, 6, 9, 12\\}$. It is simpler to calculate the probability of an in-frame deletion, $P(F^c \\mid D)$, and subtract from $1$.\n$$P(F^c \\mid D) = P(L=3 \\mid D) + P(L=6 \\mid D) + P(L=9 \\mid D) + P(L=12 \\mid D)$$\nSubstituting the given values:\n$$P(F^c \\mid D) = 0.15 + 0.08 + 0.03 + 0.01 = 0.27$$\nThe probability of a frameshift given a deletion is therefore:\n$$P(F \\mid D) = 1 - P(F^c \\mid D) = 1 - 0.27 = 0.73$$\n\nFinally, we substitute these conditional probabilities back into the law of total probability formula:\n$$P(F) = P(F \\mid I)P(I) + P(F \\mid D)P(D)$$\n$$P(F) = (0.98)\\left(\\frac{1}{3}\\right) + (0.73)\\left(\\frac{2}{3}\\right)$$\n$$P(F) = \\frac{0.98 + 2 \\times 0.73}{3} = \\frac{0.98 + 1.46}{3} = \\frac{2.44}{3}$$\n$$P(F) \\approx 0.813333...$$\n\nThe problem requires the answer to be rounded to four significant figures.\nThe required probability is $0.8133$.\n\nThe primary simplifying assumption, which is inherent to the problem's formulation, is that the specified indel distributions completely describe all possible outcomes of the NHEJ repair process at the target site, and no other types of mutations (e.g., base substitutions, larger structural variants) occur.", "answer": "$$\\boxed{0.8133}$$", "id": "2713068"}, {"introduction": "Base editors offer remarkable precision but are not without potential drawbacks, most notably the risk of \"bystander\" edits within the active window. This practice [@problem_id:2713167] focuses on quantifying the specificity of a base editing experiment by calculating the fraction of edited alleles that also contain an undesired modification. This type of analysis using conditional probability is essential for evaluating the \"purity\" of an editing outcome and is a critical step in assessing the therapeutic potential of any base editor.", "problem": "A cytidine base editor is deployed in postmitotic neurons using a guide RNA whose editable window spans positions $4$–$8$ relative to the protospacer-adjacent motif (PAM)-proximal end of the protospacer. Within this window, exactly two cytosines are present: an intended target cytosine at position $5$ and an unintended bystander cytosine at position $8$. For a given experimental regime, deep sequencing measurements on matched loci provide per-position edit probabilities for single-pass exposure: the probability that the intended target cytosine at position $5$ is converted is $p_{5} = 0.65$, and the probability that the bystander cytosine at position $8$ is converted is $p_{8} = 0.30$. Assume that editing events at distinct cytosines on the same allele occur independently, and that edits outside positions $4$–$8$ are negligible.\n\nDefine an allele as “edited” if at least one of the two window cytosines was converted, and define an “undesired bystander edit” as any conversion at position $8$ (regardless of whether the intended target at position $5$ was also converted). Starting from first principles of probability for independent Bernoulli events, compute the expected fraction of edited alleles that carry at least one undesired bystander edit. Express your final answer as a decimal and round to four significant figures.", "solution": "The problem has been validated and is deemed scientifically grounded, well-posed, and objective. It presents a standard scenario in molecular biology that can be addressed with fundamental principles of probability theory. We proceed with the solution.\n\nLet $C_5$ be the event that the cytosine at position $5$ is converted.\nLet $C_8$ be the event that the cytosine at position $8$ is converted.\n\nThe problem provides the following probabilities for single-pass editing:\n$$P(C_5) = p_{5} = 0.65$$\n$$P(C_8) = p_{8} = 0.30$$\n\nThe problem states that editing events at distinct cytosines on the same allele occur independently. Therefore, the probability of both events occurring is the product of their individual probabilities:\n$$P(C_5 \\cap C_8) = P(C_5) P(C_8) = p_{5} p_{8}$$\n\nWe must define two key events based on the problem statement.\nFirst, let $E$ be the event that an allele is “edited.” This is defined as the case where at least one of the two cytosines is converted. In set-theoretic terms, this is the union of the individual conversion events:\n$$E = C_5 \\cup C_8$$\n\nSecond, let $B$ be the event of an “undesired bystander edit.” This is defined as any conversion at position $8$. Thus:\n$$B = C_8$$\n\nThe quantity to be computed is \"the expected fraction of edited alleles that carry at least one undesired bystander edit.\" This is a conditional probability: the probability of event $B$ occurring, given that event $E$ has occurred. We denote this as $P(B|E)$.\n\nFrom the definition of conditional probability:\n$$P(B|E) = \\frac{P(B \\cap E)}{P(E)}$$\n\nWe must evaluate the numerator and the denominator.\n\nThe numerator, $P(B \\cap E)$, is the probability that an allele has a bystander edit *and* is edited. This corresponds to the intersection of events $B$ and $E$:\n$$B \\cap E = C_8 \\cap (C_5 \\cup C_8)$$\nFrom the laws of set theory, the intersection of a set with the union of itself and another set is simply the original set. That is, for any sets $A$ and $X$, $A \\cap (A \\cup X) = A$. Therefore:\n$$B \\cap E = C_8 = B$$\nThis is logical: if a bystander edit occurs (event $B=C_8$), the allele is by definition edited (event $E=C_5 \\cup C_8$), so the event \"$B$ and $E$\" is identical to event $B$.\nThe probability of the numerator is thus:\n$$P(B \\cap E) = P(C_8) = p_{8}$$\n\nThe denominator, $P(E)$, is the probability that an allele is edited at all. We calculate this using the principle of inclusion-exclusion:\n$$P(E) = P(C_5 \\cup C_8) = P(C_5) + P(C_8) - P(C_5 \\cap C_8)$$\nGiven the independence of the events:\n$$P(E) = p_{5} + p_{8} - p_{5} p_{8}$$\nAlternatively, and more reliably, we can calculate the probability of the complement of $E$, denoted $E^c$, which is the event that *no* edit occurs. By De Morgan's laws:\n$$E^c = (C_5 \\cup C_8)^c = C_5^c \\cap C_8^c$$\nThe probabilities of the individual non-conversion events are:\n$$P(C_5^c) = 1 - P(C_5) = 1 - p_{5}$$\n$$P(C_8^c) = 1 - P(C_8) = 1 - p_{8}$$\nDue to independence, the probability of no edit is:\n$$P(E^c) = P(C_5^c) P(C_8^c) = (1 - p_{5})(1 - p_{8})$$\nThe probability of at least one edit is then:\n$$P(E) = 1 - P(E^c) = 1 - (1 - p_{5})(1 - p_{8})$$\n\nCombining these results, the conditional probability is:\n$$P(B|E) = \\frac{p_{8}}{1 - (1 - p_{5})(1 - p_{8})}$$\n\nNow, we substitute the numerical values provided: $p_5 = 0.65$ and $p_8 = 0.30$.\nFirst, calculate the denominator, $P(E)$:\n$$P(E) = 1 - (1 - 0.65)(1 - 0.30)$$\n$$P(E) = 1 - (0.35)(0.70)$$\n$$P(E) = 1 - 0.245$$\n$$P(E) = 0.755$$\nThe numerator is $P(B \\cap E) = p_8 = 0.30$.\nTherefore, the desired fraction is:\n$$P(B|E) = \\frac{0.30}{0.755}$$\n$$P(B|E) \\approx 0.397350993...$$\n\nThe problem requires the answer to be rounded to four significant figures. The first four significant figures are $3$, $9$, $7$, and $3$. The fifth significant figure is $5$, which requires rounding up the last digit.\n$$P(B|E) \\approx 0.3974$$", "answer": "$$\\boxed{0.3974}$$", "id": "2713167"}]}